Printer Friendly

Ivax Diagnostics Inc (Miami FL), which makes medical and lab test products, reported a third-quarter loss on lower test sales and contract manufacturing revenue.

Ivax Diagnostics Inc (Miami FL), which makes medical and lab test products, reported a third-quarter loss on lower test sales and contract manufacturing revenue. Ivax posted a loss of $1.2 million, or 4 cents per share, compared with profit of $18,963, or no reported earnings per share. Revenue fell 16% to $4.6 million from $5.4 million. The company said an anticipated sales force restructuring and new products should help its 2010 financial results. "Since the beginning of the year we have laid the groundwork to make our company stronger and more efficient, through a thorough evaluation of our operations, our distribution agreements, manufacturing facilities and product offerings," said President and CEO Charles Struby.

Shares of Ivax closed the week unchanged at 55 cents on the AMEX Exchange. The stock has traded between 28 cents and 84 cents over the past 52 weeks.
COPYRIGHT 2009 MedContent Media, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:MondayMorning
Article Type:Brief article
Date:Nov 16, 2009
Words:146
Previous Article:China is the place to be for Western drugmakers seeking insurance against slowing growth, but plenty of other emerging markets are also tempting for...
Next Article:Eli Lilly & Co (Indianapolis IN) said Friday its science and technology head will retire.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters